CompanyGraph
What stands out
- Valued far above the size of its business
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleMarket cap is $2.26B, above the global median of $1.15B
- PositionCurrent ratio is 9.41×, higher than 95% of its Medical Instruments & Supplies peers (median 2.98×)
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.06%
Annual Rate
CNY 0.05Paid annual
Payout Ratio
59.4%Sustainable
Last Ex-Dividend
Jul 16, 2026
The reported statements, read against the company's own industry.
What stands out
- Valued far above the size of its business
Financials view
Market Capitalization
15.22BCNY2.26B · vs all stocks (USD)
Trailing P/E
400.10xvs Medical Instruments & Supplies peers
Revenue (TTM)
603.43MCNY89.62M · vs all stocks (USD)
Profit Margin
7.03%vs Medical Instruments & Supplies peers
Beta
0.9010xvs all stocks
52-Week Change
212.38%vs all stocks
Market Capitalization
15.22BCNY2.26B · vs all stocks (USD)
Enterprise Value
15.97BCNY2.37B · vs all stocks (USD)
Trailing P/E
400.10xvs Medical Instruments & Supplies peers
Forward P/E
123.50xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
28.26xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
7.75xvs Medical Instruments & Supplies peers
Enterprise to Revenue
26.47xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
158.37xvs Medical Instruments & Supplies peers
Gross Margin
37.22%vs Medical Instruments & Supplies peers
Profit Margin
7.03%vs Medical Instruments & Supplies peers
Operating Margin
-2.56%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
0.79%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
1.87%vs Medical Instruments & Supplies peers
Revenue (TTM)
603.43MCNY89.62M · vs all stocks (USD)
Revenue per Share (TTM)
2.89CNYUpdated Aug 20, 2026Quarterly Revenue Growth
-11.00%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
230.83MCNY34.28M · vs all stocks (USD)
EBITDA (TTM)
133.14MCNY19.77M · vs all stocks (USD)
Net Income (TTM)
42.41MCNY6.30M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-96.70%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
133.39MCNY19.81M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-58.10MCNY-8.63M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.0500CNYUpdated Aug 20, 2026Trailing Annual Dividend Yield
0.06%vs all stocks
Payout Ratio
59.40%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
4.17MCNYFY2025 · Dec 31, 2025Revenue
619.45MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
378.66MCNYFY2025 · Dec 31, 2025Gross Profit
240.79MCNYFY2025 · Dec 31, 2025Operating Income
57.49MCNY8.54M · vs all stocks (USD)
Pre-tax Income
69.13MCNYFY2025 · Dec 31, 2025Income Tax Expense
9.27MCNYFY2025 · Dec 31, 2025Net Income
59.86MCNYFY2025 · Dec 31, 2025EBIT
70.49MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
133.14MCNYFY2025 · Dec 31, 2025Research & Development
39.51MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
68.89MCNYFY2025 · Dec 31, 2025Other Operating Expenses
8.53MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
2.09MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
1.35MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.3670CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.3670CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
163.97MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
163.97MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
59.86MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
311.88KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
43.14MCNYFY2025 · Dec 31, 2025Free Cash Flow
-88.73MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
338.06MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
59.86MCNYFY2025 · Dec 31, 2025Other Non-cash Items
14.07MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-1.68MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-29.12MCNYFY2025 · Dec 31, 2025Capital Expenditures
-131.86MCNYFY2025 · Dec 31, 2025Purchase of Investments
-3.49BCNYFY2025 · Dec 31, 2025Sale of Investments
3.49BCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-138.76MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
126.00MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-40.00MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-26.19MCNYFY2025 · Dec 31, 2025Other Financing Charges
-76.08MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-16.27MCNYFY2025 · Dec 31, 2025Shares Outstanding
213.46MSharesUpdated Aug 20, 2026Float Shares
145.06MSharesUpdated Aug 20, 2026% Held by Insiders
34.45%vs all stocks
% Held by Institutions
21.15%vs all stocks
Total Cash (MRQ)
1.18BCNY175.71M · vs all stocks (USD)
Total Cash per Share (MRQ)
5.55CNYUpdated Aug 20, 2026Total Debt (MRQ)
83.54MCNY12.41M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0379xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
9.41xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
10.33CNYUpdated Aug 20, 2026Total Assets
2.55BCNY379.02M · vs all stocks (USD)
Total Current Assets
1.71BCNYFY2025 · Dec 31, 2025Total Liabilities
355.47MCNYFY2025 · Dec 31, 2025Total Non-current Assets
845.31MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
169.12MCNYFY2025 · Dec 31, 2025Total Current Liabilities
186.35MCNYFY2025 · Dec 31, 2025Cash
338.05MCNYFY2025 · Dec 31, 2025Cash Equivalents
16.10MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
354.16MCNYFY2025 · Dec 31, 2025Other Short-term Investments
845.32MCNYFY2025 · Dec 31, 2025Accounts Receivable
182.82MCNYFY2025 · Dec 31, 2025Inventory
154.14MCNYFY2025 · Dec 31, 2025Accounts Payable
112.83MCNYFY2025 · Dec 31, 2025Short-term Debt
7.41MCNYFY2025 · Dec 31, 2025Other Current Liabilities
196.23KCNYFY2025 · Dec 31, 2025Long-term Debt
83.33MCNYFY2025 · Dec 31, 2025Common Stock (Book)
164.20MCNYFY2025 · Dec 31, 2025Retained Earnings
454.08MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
2.20BCNY326.23M · vs all stocks (USD)
Treasury Stock
34.90MCNYFY2025 · Dec 31, 202552-Week Low
24.98CNYUpdated Aug 20, 202652-Week High
110.31CNYUpdated Aug 20, 202652-Week Change
212.38%vs all stocks
Beta
0.9010xvs all stocks
50-Day MA
81.90CNYUpdated Aug 20, 2026200-Day MA
64.71CNYUpdated Aug 20, 2026Avg 10-Day Volume
6.86MSharesUpdated Aug 20, 2026Avg 30-Day Volume
6.07MSharesUpdated Aug 20, 2026Diluted EPS (TTM)
0.2000CNYUpdated Aug 20, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Current ratio is 9.41×, higher than 95% of its Medical Instruments & Supplies peers (median 2.98×)Significant
Current ratio: 9.41Industry median: 2.98Industry P95: 8.21Peers compared: 35.00
P/E ratio is 400.1×, higher than 95% of its Medical Instruments & Supplies peers (median 41.06×)Significant
P/E ratio: 400.1Industry median: 41.06Industry P95: 180.515Peers compared: 35.00
Structural Tensions
Valued far above the size of its businessSignificant
Price-to-Sales: 28.26Revenue Growth YoY: -0.11
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $2.26B, above the global median of $1.15BNotable
Market cap (USD): 2,260,431,528.959Global Median: 1,146,734,693.424
Companies that share the same coordination system — how they create, deliver, or capture value.
Mtar Technologies Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Advanced Echem Materials Company Limited
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Wuhan Yangtze Communication Industry Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Shanghai Hanbell Precise Machinery Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Shandong Hi-Tech Spring Material Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Simplo Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Pradiksi Gunatama Tbk.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Malayan Cement Berhad
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shenzhen Microgate Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Suzhou UIGreen Micro&Nano Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Olaplex Holdings, Inc.
1 interpretationLow-Leverage Liquidity Configuration
Data Patterns (India) Limited
1 interpretationLow-Leverage Liquidity Configuration
Enliven Therapeutics, Inc.
1 interpretationLow-Leverage Liquidity Configuration